Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

Integrating novel multi-ancestry PRS methods (e.g., PROSPER/PRS-CSx) with GWAS across ancestries enhances prediction accuracy for AD risk among Hispanic population. APOE and PRS may point to different ...

- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s ...

- Voyager's wholly-owned Alzheimer's disease franchise now includes clinical-stage anti-tau antibody VY7523 as well as gene therapies targeting tau, amyloid, and APOE - ...

Voyager Therapeutics announces a new program targeting APOE4 in Alzheimer's patients, combining gene therapy and novel delivery methods.

The APOE gene is considered the strongest genetic risk factor for Alzheimer’s disease, with the APOE4 variant strongly linked to higher risk and the APOE2 variant associated with lower risk.

- Voyager’s wholly-owned Alzheimer’s disease franchise now includes clinical-stage anti-tau antibody VY7523 as well as gene therapies targeting tau, amyloid, and APOE - ...

Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach- New program combines IV-delivered TRACER™ capsid with ...

We identified Apoe as a critical protective gene that is downregulated in low-temperature conditions. The reduction in APOE levels correlates with increased lipid accumulation in cartilage, leading to ...

The Department of Homeland Security is preparing to cut nearly 75% of staffing at the agency’s office tasked with developing and sharing threat intelligence with state and local partners ...